Incyte

Yahoo Finance • 20 hours ago

AbbVie sees negative Q3, full-year impact from IPR&D and milestones expense

[AbbVie] hapabapa * AbbVie (NYSE:ABBV [https://seekingalpha.com/symbol/ABBV#hasComeFromMpArticle=false#source=section%3Amain_content%7Cbutton%3Abody_link%7Cfirst_level_url%3Anews]) said it will incur a negative impact of $1.50 to GAAP a... Full story

Yahoo Finance • yesterday

J&J upgraded at Wells Fargo on valuation, pharma potential

[Johnson & Johnson Medical Products company in Markham, Ontario] JHVEPhoto/iStock Editorial via Getty Images * Wells Fargo upgraded Johnson & Johnson JNJ) to over-weight from equal weight saying that the healthcare giant is attractively... Full story

Yahoo Finance • 2 days ago

State attorneys general fail in bid to halt changes to ACA marketplace

[Words Affordable Care Act ACA written on a paper.] A federal judge in Boston has denied a motion filed by a group of state attorneys general seeking to block the Trump administration from making changes to the Affordable Care Act's healt... Full story

Yahoo Finance • 2 days ago

Nanobiotix gains after early-stage trial data for J&J-partnered cancer drug

[Cancer cells vis] koto_feja Nanobiotix (NASDAQ:NBTX [https://seekingalpha.com/symbol/NBIX]) traded higher on Thursday after the French biotech announced initial results from a Phase 1 trial for JNJ-1900 (NBTXR3), a cancer injection devel... Full story

Yahoo Finance • 2 days ago

INCY and ABBV lead S&P 500 healthcare gainers in Q3; MOH and ALGN lag

[Sector index data, health care, industrials, insurance.] Torsten Asmus/iStock via Getty Images The Health Care Select Sector SPDR® Fund ETF (NYSEARCA:XLV [https://seekingalpha.com/symbol/XLV]), which tracks the health care sector, and... Full story

Yahoo Finance • 7 days ago

China Medical System (867.HK; 8A8.SG) Positive Results from China Phase 3 Clinical Trial of Innovative Drug Ruxolitinib Cream with AD Indication

SHENZHEN, CHINA, Sept. 28, 2025 (GLOBE NEWSWIRE) -- China Medical System Holdings Limited (“CMS”) is pleased to announce that its subsidiaries, Dermavon Holdings Limited (“Dermavon”, an innovative pharmaceutical company specialized in sk... Full story

Yahoo Finance • 7 days ago

Incyte (INCY) Advances Clinical Trials for Povorcitinib Across Multiple Conditions

Incyte Corporation (NASDAQ:INCY) ranks among the most undervalued NASDAQ stocks to buy now. Citizens JMP reaffirmed its Market Perform rating on Incyte Corporation (NASDAQ:INCY) on September 18 after the company revealed updated clinical t... Full story

Yahoo Finance • 9 days ago

Jim Cramer Calls Incyte “Way Too Cheap”

Incyte Corporation (NASDAQ:INCY) is one of the relatively cheap S&P 500 stocks Jim Cramer talked about. Cramer mentioned that it is the healthcare stock that “stands out” to him. He stated: “What else? Now, we know healthcare has been mos... Full story

Yahoo Finance • 13 days ago

Notable healthcare headlines for the week: Novo Nordisk, Hims & Hers and UnitedHealth in focus

Wall Street finished the week on a strong note as all three major market averages tagged record levels on Friday. For the week, the Nasdaq (COMP:IND), S&P 500 (SP500), and Dow (DJI) rose by 2.21%, 1.22%, and 1.05%, respectively. The S&P... Full story

Yahoo Finance • 16 days ago

Incyte gets FDA nod for Opzelura cream in atopic dermatitis treatment

[Nothing but the best brands for their customers] AlexanderFord/E+ via Getty Images * Incyte (NASDAQ:INCY [https://seekingalpha.com/symbol/INCY]) announced that the U.S. FDA has approved Opzelura (ruxolitinib) cream 1.5%, for the chroni... Full story

Yahoo Finance • 19 days ago

Alger Russell Innovation Index Updates for Third Quarter 2025

NEW YORK, Sept. 15, 2025 /PRNewswire/ -- Fred Alger Management, LLC ("Alger"), a privately held growth equity investment manager, today announced the quarterly rebalancing of the Alger Russell Innovation Index ("Index"). Following the clos... Full story

Yahoo Finance • 22 days ago

Uncover the latest developments among S&P500 stocks in today's session.

Curious about the top performers within the S&P500 index one hour before the close of the markets on Friday? Dive into the list of today's session's top gainers and losers for a comprehensive overview. [topmovers] TODAY'S TOP GAINERS... Full story

Yahoo Finance • 23 days ago

Incyte Corporation (INCY) Advances KRAS Cancer Program

In this article, we will be taking a look at the 11 Best Performing Biotech Stocks So Far in 2025. Incyte Corporation is one of them. Incyte Corporation (NASDAQ:INCY), a global biopharmaceutical company based in Wilmington, Delaware, is s... Full story

Yahoo Finance • last month

Tuesday's session: top gainers and losers in the S&P500 index

Uncover the latest developments among S&P500 stocks in today's session. Stay tuned to the S&P500 index's top gainers and losers on Tuesday. [topmovers] GAINERS TICKER CHANGE COMMENT ULTA [https://www.chartmill.com/stock/quote... Full story

Yahoo Finance • last month

Large-cap biotech is a sector to watch for investors: Analysts

Wall Street is looking for new ways to park cash in healthcare names, and large-cap biotechs have begun to gain steam. This asset class differs from traditional large-cap pharmaceutical companies — typically with a $200 billion market cap... Full story

Yahoo Finance • last month

Incyte Corp (NASDAQ:INCY): A Prime Candidate for Value Investors Seeking Undervalued Stocks

In value investing, the search for undervalued stocks is a long-established method focused on finding companies trading for less than their true worth. This strategy, created by Benjamin Graham and developed further by investors including... Full story

Yahoo Finance • last month

Notable healthcare headlines for the week: Novo Nordisk, Medtronic, Novavax in focus

Wall Street jumped sharply on Friday, with the Dow hitting a fresh all-time high as investors welcomed Federal Reserve Chair Jerome Powell’s remarks at Jackson Hole. The S&P 500 Health Care Index Sector (NYSEARCA:XLV [https://seekingalpha... Full story

Yahoo Finance • last month

Cytokinetics Names Jim Daly to Board of Directors

Cytokinetics, Incorporated SOUTH SAN FRANCISCO, Calif., Aug. 20, 2025 (GLOBE NEWSWIRE) -- Cytokinetics, Incorporated (Nasdaq: CYTK) today announced the appointment of James M. Daly to its Board of Directors effective August 19, 2025. Mr.... Full story

Yahoo Finance • 2 months ago

Notable healthcare headlines for the week: UnitedHealth, Eli Lilly, Pfizer in focus

Wall Street’s major averages ended mostly lower on Friday, as market participants have been keeping an eye on the highly anticipated meeting between Donald Trump and Vladimir Putin. However, the S&P 500 Health Care Index Sector (NYSEARCA:... Full story

Yahoo Finance • 2 months ago

Cancer Stock Soars While This China Tech Stock Heads To New Highs

Cancer stock Incyte soared on earnings and touched a new high on Friday. Also at new highs, Lidar maker Hesai group shows ideal relative strength. Continue Reading View Comments... Full story